ACVRL1 and hereditary hemorrhagic telangiectasia: Furthermore, Harrison et al. reported that a PAH patient harboring a missense ACVRL1 mutation had no family or personal history of HHT, nor any evidence of HHT at necropsy (Harrison et al., 2003).